The FDA has qualified the first AI-based drug development tool to support metabolic dysfunction-associated steatohepatitis clinical trials. The cloud-based tool, AI-Based Histologic Measurement of ...
When damage to the liver caused by alcohol or viral infections persists, liver fibrosis progresses and replaces tissue with ...
What began as a student’s exploration with data has since turned into a tool that may predict patients’ risk of advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback